Recruiting
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
ClinicalTrials.gov IDNCT06935513
PhaseNA
Enrollment300
SponsorAffiliated Hospital of Nantong University
Age30 Years and older
SexALL
Conditions studied
Hypertension, Diabetes, Atrial Fibrillation, Dyslipidemia, Smoking, Physical Inactivity, Obesity and Overweight
About this study
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Interventions
- Behavioral: Wearable Devices — Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.
Primary outcomes
- medication adherence and risk factor control rates (6 months)
Eligibility information
Inclusion Criteria:
1. Diagnosed with hypertension;
2. Diagnosed with diabetes;
3. Diagnosed with atrial fibrillation;
4. Smoking subjects;
5. Physical inactive subjects;
6. Obesity and overweight subjects;
7. Must be able to use smart wearable devices.
Exclusion Criteria:
1. Diagnosed with malignancies;
2. Diagnosed with psychiatric disorders;
3. Diagnosed with cognitive impairment;
4. Unable to operate smart wearable devices.
Study locations
- Affiliated Hospital of Nantong University, Nantong, Jiangsu 226000 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-17.